RxDoctor Payments Data

Brian Coppinger, MD

Family Medicine · Whiteland, INNPI 1649407685

Payments from drug & device makers

$477in general payments, 2019–2025

Across 31 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$261
  • Novo Nordisk$45
  • Medtronic$41
  • Boehringer Ingelheim$34
  • Astellas Pharma US Inc$22
  • Axonics, Inc.$18
  • plus $55 from 4 others

What the payments were for

  • Food & beverage$477100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$477 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$55,659
Medicare patients
190
Services billed
1,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$44,903
EliquisApixaban34$43,593
OzempicSemaglutide35$35,264
MounjaroTirzepatide26$28,885
JardianceEmpagliflozin17$28,826
MyrbetriqMirabegron22$17,727
LinzessLinaclotide14$14,478
ShingrixVaricella-Zoster Ge/As01b/Pf37$8,217
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$5,569
Varenicline Tartrate11$5,523
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$4,059
Omeprazole218$3,794
Gabapentin104$2,788
Atorvastatin Calcium355$2,768
Albuterol Sulfate HfaAlbuterol Sulfate63$2,204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Shingrix$261$53,12068 claims
PfizerEliquis$16$43,59334 claims
Novo NordiskOzempic$45$35,26435 claims
Lilly USA, LLCMounjaro$13$28,88526 claims
Boehringer IngelheimJardiance$34$28,82617 claims
Astellas Pharma US IncMyrbetriq$22$17,72722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Whiteland

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →